Home›Stock Screener›HMT›Intrinsic Value

HMT Intrinsic Value

HMT intrinsic value. HMT (HMT) median intrinsic value is ₹23.41 from 2 valuation models (range ₹18–₹23), vs current price ₹58.53 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Compare with HMT fair value estimate to assess whether the stock is under or overvalued.

Market Price (CMP)
₹58.53
Primary Intrinsic Value
₹17.56
Market Cap
₹2084 Cr
-60.0% Downside
Median Value
₹23.41
Value Range
₹18 - ₹23
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

HMT Valuation Methods Summary — DCF, Graham Number & P/E

HMT intrinsic value across 2 models vs current price ₹58.53 — upside/downside and value range per method. For current market price and key ratios, visit HMT share price today.

Method Type Intrinsic Value Range Upside/Downside Details
Revenue Multiple Method revenue ₹17.56 ₹15.80 - ₹19.32 -70.0% Revenue/Share: ₹9.66, P/S: 0.8x
Simple DCF (5Y) dcf ₹23.41 ₹18.73 - ₹28.09 -60.0% CF Growth: 5.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

HMT Intrinsic Value vs Market Price — All Valuation Models

HMT fair value range ₹18–₹23 vs current market price ₹58.53 across 2 valuation models. Read HMT dividend track record for the complete payout history and dividend yield track record.

HMT Intrinsic Value Analysis — Undervalued or Overvalued?

HMT median intrinsic value ₹23.41, current price ₹58.53 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.

What is the intrinsic value of HMT?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of HMT (HMT) is ₹23.41 (median value). With the current market price of ₹58.53, this represents a -60.0% variance from our estimated fair value.

The valuation range spans from ₹17.56 to ₹23.41, indicating ₹17.56 - ₹23.41.

Is HMT undervalued or overvalued?

Based on our multi-method analysis, HMT (HMT) appears to be trading above calculated value by approximately 60.0%.

HMT Financial Health — Key Ratios vs Industry Benchmarks

HMT financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 3.78 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 7.5% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -42.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.64x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

HMT Cash Flow Quality — Operating & Free Cash Flow

HMT operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹44 Cr ₹44 Cr Positive Free Cash Flow 8/10
March 2025 ₹-46 Cr ₹-46 Cr Negative Cash Flow 3/10
March 2024 ₹-847 Cr ₹-871 Cr Negative Cash Flow 3/10
March 2023 ₹103 Cr ₹89 Cr Positive Free Cash Flow 8/10
March 2022 ₹-50 Cr ₹-50 Cr Negative Cash Flow 3/10